companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

PARTING CREEK RD.

WATTSVILLE-USA

Company Name:
Corporate Name:
PARTING CREEK RD.
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: P.O.Box 145,WATTSVILLE,VA,USA 
ZIP Code:
Postal Code:
23483 
Telephone Number: 7574422364 (+1-757-442-2364) 
Fax Number:  
Website:
jcarve. com 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
1255 
USA SIC Description:
All 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
WATERFORD REAL ESTATE
FLOWER PRESERVATION BY WATERFORD PAST-THYMES
PARTING CREEK GIFT WORLD
Next company profile:
JOHNSTONE,CHRIS
BROAD WATER ROSE JEWELS
COMPUTER VILLAGE










Company News:
  • Ascendis Pharma: Patients. Science. Passion.
    Our unwavering focus Ascendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives
  • About Us - Ascendis Pharma
    Ascendis Pharma was founded in 2007 based on the innovative TransCon technology platform We are headquartered in Copenhagen, Denmark and are publicly traded, following an initial public offering in 2015 (Nasdaq: ASND) We have employees working across the globe to improve patients’ lives
  • Pipeline - Ascendis Pharma
    Our pipeline of innovative new therapies is driven by the flexibility of our TransCon technologies and our aim to improve patients' lives Ascendis and its partners have multiple prodrug therapies in development Each product candidate is unique and designed to be a best-in-class therapy
  • OUR PRODUCTS - Ascendis Pharma
    Ascendis Pharma medicines using TransCon technology are authorized for the indications and in the countries or regions shown below Please note that in some countries, a medicine may be authorized for marketing but not yet commercially available
  • Contact Us - Ascendis Pharma
    Ascendis is headquartered in Denmark and has offices in Germany and in Palo Alto, CA , Princeton, NJ in the U S
  • Leadership | Ascendis Pharma
    He currently serves on the boards of Ascendis Pharma A S (NASDAQ: ASND) and KalVista Pharmaceuticals (NASDAQ: KALV), and has previously served on the boards of Aclaris Therapeutics (NASDAQ: ACRS), Biohaven Pharmaceuticals (NYSE: BHVN), and many other private and public biopharmaceutical companies
  • Careers | Ascendis Pharma
    As Ascendis grows, we are always looking to connect with individuals who are passionate about making a meaningful difference for patients If you don’t see an open role that fits your skills and would like to be considered for future opportunities, we encourage you to upload your resume to our country-specific talent pools listed here:
  • Endocrinology | Ascendis Pharma
    Consistent with our strategic roadmap for growth, we plan to further grow these candidates through label expansion and global clinical reach, either directly or through partnerships Our science aims to make a difference for patients, caregivers, and healthcare providers as we build a potentially best-in-class endocrinology rare disease portfolio
  • Technology - Ascendis Pharma
    At the core of Ascendis Pharma is a powerful, flexible technology platform that uses advanced knowledge of chemistry to overcome challenges of developing new therapeutics When applied using known biology, this technology platform helps us address unmet patient needs in unprecedented ways
  • Ascendis Pharma A S
    YORVIPATH’s titration scheme was only evaluated in adults who first achieved an albumin-corrected serum calcium of at least 7 8 mg dL using calcium and active vitamin D treatment




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer